Quick Answer
NEOGENOMICS INC reported Total Assets of $1.36 billion for the year ending 2025.
- NEOGENOMICS INC showed a decrease of -17.0% in Total Assets from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $17.49 million | Q1 2012: $26.44 million | Q3 2012: $29.30 million | Q1 2013: $33.62 million | Q2 2013: $34.46 million | Q3 2013: $35.23 million | Q1 2014: $42.32 million | Q2 2014: $43.64 million | Q3 2014: $78.82 million | Q1 2015: $81.16 million | Q2 2015: $82.97 million | Q3 2015: $83.74 million | Q1 2016: $346.84 million | Q2 2016: $351.56 million | Q3 2016: $355.43 million | Q1 2017: $343.64 million | Q2 2017: $339.88 million | Q3 2017: $343.90 million | Q1 2018: $349.27 million | Q2 2018: $345.78 million | Q3 2018: $455.14 million | Q1 2019: $533.34 million | Q2 2019: $696.67 million | Q3 2019: $711.16 million | Q1 2020: $732.25 million | Q2 2020: $945.49 million | Q3 2020: $959.43 million | Q1 2021: $1.49 billion | Q2 2021: $1.90 billion | Q3 2021: $1.91 billion | Q1 2022: $1.83 billion | Q2 2022: $1.79 billion | Q3 2022: $1.76 billion | Q1 2023: $1.71 billion | Q2 2023: $1.70 billion | Q3 2023: $1.68 billion | Q1 2024: $1.64 billion | Q2 2024: $1.64 billion | Q3 2024: $1.64 billion | Q1 2025: $1.60 billion | Q2 2025: $1.39 billion | Q3 2025: $1.37 billion.
- Over the full 16 years of available data (2010 to 2025), NEOGENOMICS INC's Total Assets has grown by 9,861.4%.
- Historical annual values: Fiscal year 2025: $1.36 billion | Fiscal year 2024: $1.64 billion | Fiscal year 2023: $1.68 billion | Fiscal year 2022: $1.74 billion | Fiscal year 2021: $1.87 billion | Fiscal year 2020: $988.33 million | Fiscal year 2019: $709.51 million | Fiscal year 2018: $505.02 million | Fiscal year 2017: $344.45 million | Fiscal year 2016: $337.12 million | Fiscal year 2015: $351.29 million | Fiscal year 2014: $81.11 million | Fiscal year 2013: $39.92 million | Fiscal year 2012: $30.07 million | Fiscal year 2011: $19.95 million | Fiscal year 2010: $13.65 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: